Peter Attia, host of The Drive Podcast, delivers a comprehensive overview of colorectal cancer screening in this sneak peek episode. As a physician focused on longevity medicine, Attia emphasizes the preventable nature of colorectal cancer and the critical importance of proper screening protocols.

The episode covers the biology of colorectal cancer development, the unique advantages of colonoscopy as both a screening and preventive tool, the concerning rise in early-onset cases among younger adults, and the growing landscape of non-invasive screening alternatives including stool-based and blood-based tests.

The Preventable Cancer Crisis

Colorectal cancer ranks as the second leading cause of cancer death in the United States, behind only lung cancer, with approximately 55,000 projected deaths this year according to the American Cancer Society.

Despite being "arguably the most preventable cancer we know of," a 2020 CDC estimate shows 68% of colorectal cancer deaths could be prevented with screening at traditional recommended intervals - Peter Attia.

"We're talking about a cancer that in most cases gives us a decades-long window to intervene, and we're still losing nearly 70% of people out of that 55,000 deaths a year because they never walked through the front door to get a colonoscopy" - Peter Attia.

Why Colorectal Cancer is Uniquely Screenable

CRC follows a well-characterized, slow progression from normal tissue to benign polyp, to precancerous polyp, to frank malignancy, typically taking years or often a decade or more.

The colon is a hollow organ that "sits outside the body" allowing direct access and visualization, unlike other cancer screening methods that can only detect existing cancer.

Colonoscopy serves dual purposes: "not only detect those precancerous lesions, but also remove them before they ever become cancer" - a capability no other common cancer screening test can match.

Aggressive Screening for Maximum Prevention

Peter Attia argues this prevention rate "could be closer to 100%, i.e. 100% reduction in colorectal cancer death with more aggressive screening protocols, including starting earlier and screening more often."

The episode promises to address screening for people "whether you're 35 and wondering when to start or 55 and wondering when your Cologuard test is good enough."

Topics covered include colonoscopy preparation, ensuring high-quality exams, screening intervals, real risks and trade-offs, and the growing landscape of non-invasive alternatives.

Resources Mentioned

Ethics for Behavior Analysts

f course. Third, delivery of our premium newsletter, which is put together by our dedicated team of research analysts. This newsletter covers a wide range of topics related to longevity and provides m